SCHEMBL6669711

SCHEMBL6669711

FC1(F)[C@@H]2c3ccccc3[C@@H](N3CCNCC3)c3ccccc3[C@@H]21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 1/20 0.40
ABCB1 P08183 2/20 0.39
HPGD P15428 1/20 0.37
KMT2A Q03164 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
HTR2C P28335 2/20 0.36
CHRM2 P08172 1/20 0.35
CHRM1 P11229 1/20 0.35
CHRM3 P20309 1/20 0.35
USP2 O75604 1/20 0.35
GBA1 P04062 1/20 0.35
ALOX15 P16050 1/20 0.35
HK1 P19367 1/20 0.35
HKDC1 Q2TB90 1/20 0.35
SIGMAR1 Q99720 2/20 0.35
HTR3E A5X5Y0 1/20 0.35
HTR3B O95264 1/20 0.35
ADRB1 P08588 1/20 0.35
HTR3A P46098 1/20 0.35
HTR3D Q70Z44 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25579654 0.79 TAAR1 (0.44) TAAR1HPGDKMT2ASMN1; SMN2HTR2C
SCHEMBL8067779 0.77 TAAR1 (0.42) TAAR1HPGDKMT2ASMN1; SMN2HTR2C
SCHEMBL1798685 0.77 CYP1A2 (0.53) TAAR1KMT2ASMN1; SMN2HTR2C
Hydrochloric Acid SCHEMBL6167962 0.75 CYP1A2 (0.52) TAAR1HPGDKMT2ASMN1; SMN2HTR2C
SCHEMBL6161969 0.74 TAAR1 (0.58) TAAR1FNTAFNTB
SCHEMBL8118171 0.74 OPRM1 (0.47) TAAR1HPGDKMT2ASMN1; SMN2HTR2C
SCHEMBL8239748 0.74 TAAR1 (0.50) TAAR1HPGDKMT2ASMN1; SMN2HTR2C
SCHEMBL8446859 0.72 KDM1A (0.44) TAAR1HPGDKMT2ASMN1; SMN2CHRM2
SCHEMBL1524562 0.72 MAPT (0.44) TAAR1HPGDKMT2ASMN1; SMN2USP2
SCHEMBL16876680 0.69 ALDH1A1 (0.44) TAAR1HPGDKMT2ASMN1; SMN2HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1198462-B1 PROCESS FOR PREPARING A 10,11-METHANODIBENZOSUBERANE DERIVATIVE LILLY CO ELI (US) 2004-09-29 EP disclosed
US-6624304-B1 Halogenation, hydrofluorination, cyclization, salt formation, cyclization; reaction with piperazine; separation ELI LILLY AND COMPANY 2003-09-23 US disclosed
US-6570016-B1 Therapy for drug resistant cancer ELI LILLY AND COMPANY 2003-05-27 US disclosed